Takahito Nakaya

2PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 20, 2024
Can FDG-PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non-small cell lung cancer?

Hideto Iguchi, Hiroaki Akamatsu, Yoshimitsu Hirai

|Apr 29, 2024
Neoadjuvant nivolumab plus chemotherapy followed by resection for superior sulcus tumour with high PD-L1 expression: A case report.

Takahito Nakaya, Yoshimitsu Hirai, Hiroaki Akamatsu

Pageof 1